Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $205.6700 (-3.89%) ($205.3800 - $221.0000) on Thu. Oct. 11, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.48% (three month average) | RSI | 21 | Latest Price | $205.6700(-3.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -4% a day on average for past five trading days. | Weekly Trend | LGND declines -7.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.24% in a week (0% probabilities). VXX(-16%) TLT(-16%) VIXM(-13%) UUP(-9%) GDXJ(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.24% (StdDev 2.48%) | Hourly BBV | 0 () | Intraday Trend | -3.3% | | | |
|
Resistance Level | $255.45 | 5 Day Moving Average | $231.24(-11.06%) | 10 Day Moving Average | $247.09(-16.76%) | 20 Day Moving Average | $255.45(-19.49%) | To recent high | -25.1% | To recent low | 0% | Market Cap | $3.305b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |